Clinical Trial Update: Phase II Study of Doxorubicin and Avastin® in Sarcoma. [Phase 2]

View source ↗

Summary

Phase II study of doxorubicin plus Avastin in sarcoma was terminated, with results posted in May 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Sarcoma, Soft Tissue Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2015-05-08